Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-07-22 @ 10:02 AM
Study NCT ID:
NCT05745350
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2023-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Sponsor:
Organization: